# LISRAYA

NDC: 87211-030
Generic name: brepocitinib
Labeler / Manufacturer: Priovant Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260827

FDA application: NDA220106

## Active ingredients

- BREPOCITINIB TOSYLATE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"87211-030"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=87211-030
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5023a17b-e96a-67d4-e063-6394a90a14a7
